clinical effectiveness of biophosphates.pdf (491.4 kB)
0/0

Clinical effectiveness of bisphosphonates for prevention of fragility fractures: a systematic review and network meta-analysis

Download (491.4 kB)
poster
posted on 09.03.2020 by Jean Sanderson, Marrissa Martyn-St James, Sarah Davies, John Stevens, Edward Goka, Susie Sadler
BACKGROUND Osteoporosis is characterised by low bone mass and structural deterioration of bone tissue, with a consequent increase in susceptibility to fragility fracture. Fractures cause significant pain, disability and loss of independence and can be fatal. [1] OBJECTIVE To assess the relative efficacy of bisphosphonates (alendronate, risedronate, ibandronate and zoledronate) for the treatment of Osteoporosis using a network meta-analysis (NMA).

History

Ethics

There is no personal data or any that requires ethical approval

Policy

The data complies with the institution and funders' policies on access and sharing

Sharing and access restrictions

The data can be shared openly

Data description

  • The file formats are open or commonly used

Methodology, headings and units

  • Headings and units are explained in the files

Licence

Exports